Virbac Animal Health has launched a broad spectrum wormer for dogs called Endogard (praziquantel, pyrantel and febantel).
Virbac says Endogard offers treatment against most types of intestinal worms found commonly in dogs. It is presented in two tablet sizes for easy dosage.
Victoria Hudson, Product Manager for Endo and Ectoparasiticides, said: "While we're known for developing innovative products which help practices generate additional revenue streams, we can also support them by offering cost-effective and proven products for routine use.
Endogard is a perfect example. The efficacy of its active ingredients is well-established; it's simple for owners to administer and it's also affordable which will bring them back to the practice. It's an excellent addition to Virbac's strong range of parasite control treatments."
For further information, contact your Territory Manager or call Virbac on 01359 243243.
The interactive checklist is designed to help practitioner and farmer to work closely together to draw up a workable action plan to improve youngstock health.
MSD Animal Health ruminant veterinary adviser Kat Baxter said: "This new checklist-based tool explores, records and scores calf health performance across five core areas to identify the strengths and weaknesses of any rearing unit’s environment and processes.
"Working through a series of 10 questions within each core area – designed to tease out where a rearing unit is in terms of accepted best management practice – allows vet and farmer to quickly pinpoint any areas needing attention. What’s more, repeating the checklist every six or 12 months is a great way to keep things on track, allowing both parties to monitor progress against agreed targets. Vets can also use the scores to benchmark their clients’ farms against each other."
Vets interested in using the new checklist-based tool on farm should contact their local MSD Animal Health account manager for further information.
Elanco Animal Health is reminding vets about the importance of correctly interpreting oocyst counts in the diagnosis of coccidiosis during the post lambing period.
The company says scouring lambs that are failing to thrive should immediately ring the alarm bells for coccidiosis. Typically, oocyst counts of >20,000 per gram are cited as diagnostic for coccidiosis in sheep, but counts of up to 100,000 oocysts per gram have been reported in apparently healthy lambs and disease can also occur in the presence of low or negligible counts where there is gut damage but before oocysts have been shed.1 These discrepancies can lead to misdiagnosis and as such, oocyst counts should always be interpreted with care.
Oocysts of the fourteen Eimeria species described as specific to sheep are indistinguishable from each other by eye and only two species - E. ovinoidalis and E. crandallis, are actually pathogenic.1 For this reason, diagnosing coccidiosis based on clinical signs of diarrhoea and oocysts in their faeces alone can generate false positives. This could lead to important differentials, such as Nematodirus battus infection (for lambs at pasture) being left untreated.
According to the company, false negatives are also a concern, particularly as prompt treatment of clinical cases with an anti-coccidial, such as diclazuril (Vexocan® 2.5mg/ml oral suspension) has been proven to reduce the convalescence period.2 Shedding of oocysts varies with disease progression and faecal counts can fluctuate significantly.3 For example, a delay between the development of clinical signs and oocysts appearing in faeces is common. Another possibility is sub-clinical disease, with affected lambs showing no typical outward signs. The gut damage caused by the parasite can be significant in these animals though, adversely affecting growth rates.
Elanco says that for reliable diagnosis of coccidiosis, faecal oocyst counts should be considered alongside disease and farm history, followed with Eimeria species identification if possible. The disease typically affects groups of lambs aged between 3-8 weeks old and is often triggered by a stressor such as castration, weaning, turnout and/or bad weather. If clinical signs appear around three weeks after such an event, the suspicion of coccidiosis can be heightened. For some farms, predictable stressors cause disease outbreaks year after year and in these cases, a metaphylactic dose of Vecoxan® can be administered to susceptible lambs 14 days after the trigger event.
Finally, the company says veterinary surgeons should also not forget the importance of good management when advising farmers about coccidiosis control. Lambing pen and high traffic area hygiene and age batching lambs are essential for long term control.
References
This third biennial offering from GB’s Cattle Health and Welfare Group also contains a summary of progress on endemic disease control with advances in eradicating Bovine Viral Diarrhoea (BVD) in each country highlighted.
The Chief Veterinary Officers of UK, Scotland and Wales have welcomed the publication of the report saying that as the possible impacts of the referendum on leaving the EU are considered, the importance of a GB focus on disease control is as important as ever.
In their joint forward, Nigel Gibbens, Sheila Voas and Christianne Glossop said: "The healthier our animals, the more attractive our products. The better our animal welfare, the greater the confidence of consumers in our production systems.
"With the UK Government placing AMR at the top of its risk register alongside terrorism and pandemic ’flu, it is heartening to see that CHAWG, in common with other livestock sectors, has grasped the nettle in looking first at how the cattle sector can better capture data on use of antimicrobials."
They go on to say that addressing AMR helps address other imperatives as an emphasis on sound animal husbandry and healthy animals kept to high welfare standards will help minimise routine reliance on antimicrobials: "Success in controlling endemic disease is one area of considerable importance, and here we can highlight CHAWG’s pivotal role in the development and promotion of national disease control programmes. These include the launch of the BVDFree scheme in England earlier this year, ongoing progress with BVD eradication in Scotland, the development of a Wales BVD scheme, and the Action Johne’s initiative."
In the report’s conclusion, RSPCA’s head of farm animals Marc Cooper points out that it is clear many positive initiatives are being pursued within the industry. He said: "Notable amongst these are those associated with dairy cow genetics, eliminating BVD, the national dairy cow welfare strategy and the development of a data hub for the collation of information relating to antimicrobial use.
"Indeed, some of these are starting to realise improvements in key areas, for example, dairy cow longevity is beginning to increase, and cow fertility figures and somatic cell counts appear to be moving in the right direction.
"However, there are still ongoing concerns relating to some important health and welfare issues. For example, despite the evidence suggesting the annual prevalence levels of cattle lameness are beginning to fall, there still appears to be no centralised database for recording it."
Chairman of CHAWG Tim Brigstocke says the contributed comments are encouraging and provide positive direction for future CHAWG activities. He also reassures that while this report sees a number of advances in highly topical areas, ‘core’ activities are not being ignored. He said: "Effective farm health planning remains the bedrock of good practice. And while we tend to focus on areas which need improvement, it’s worth mentioning that a delegation from the Food & Veterinary Office (FVO) of the European Commission recently visited and were impressed by the coordinated approach taken in this country."
The report can be downloaded from www.chawg.org.uk.
Axiom Laboratories has launched MiPetAllergy, a pet allergy test which the company says is not affected by medication and which requires no withdrawal period prior to testing.
Axiom developed the MiPetAllergy in partnership with ALK, which makes Artuvetrin. With its food elimination diet selector tool, developed in association with Royal Canin, it tests against as many as 80 environmental allergens and foods.
Dan Sherry, General Manager at Axiom, said: "Allergies are increasing among companion animals and identifying accurately which allergen is causing the problem in a particular pet can be one of the toughest challenges veterinary staff face in practice.
"MiPetAllergy represents two and half years of research so we are delighted to announce its arrival. Axiom is confident that there will be complete concordance between the screen and panel results that they are offering a money back guarantee if they are discordant. We hope it will help practices dealing with allergy patients to identify and treat for the specific allergens causing their symptoms."
Martyn Carpenter, Director of Axiom, added: "The introduction of the MiPetAllergy testing is timely as it coincides with the change in Axiom’s supplier of immunotherapy. During November and December 2014 the Veterinary Medicines Directorate (VMD) started rejecting applications for STC’s and advising that European Licensed immunotherapy products should now be used in the UK as part of the Cascade. Both our new allergy test and new vaccines are manufactured by the same company."
The company says the new test overcomes a major shortcoming in faecal egg counts: that they can only detect the presence of egg-laying adult worms. The new test, by contrast, can detect all stages of the small redworm life cycle, including the important encysted larval phase.
ADB says the new test will help protect the effectiveness of moxidectin, the only dewormer which is capable of eliminating the encysted stages and against which widespread resistance is not thought to have developed.
Whereas before, routine winter treatment was needed to target the encysted phase, this new test means the drug can be kept for when it is really needed, which will help prevent the development of resistance. ADB says it will also be of great value to equine vets in making differential diagnoses.
The blood test was developed by Prof Jacqui Matthews’ group at the Moredun Research Institute (MRI), with funding from The Horse Trust. She said: "It is great to see the commercialisation of this much-needed test to support sustainable worm control in horses. The test fills an important gap in our diagnostic toolbox and will enable horse owners to work with their veterinarians in targeting anthelmintic treatments against cyathostomin infections and hence help protect these important medicines for the future."
Dr Corrine Austin from ADB said: "ADB is now developing laboratory ELISA kits to enable independent veterinary laboratories to conduct blood testing; these kits are expected to reach market during 2020. Research into the saliva-based test is ongoing and is expected to be commercialised several years from now."
Veterinary practices can contact ADB at info@austindavis.co.uk to register interest in the diagnostic test service.
To help practices make the most of the week, TVM is providing waiting room displays, client leaflets, social media packs and online information to help educate pet owners on the symptoms of poor eye health.
The company will also be holding an webinar for vets and nurses which will be published during the week.
Will Peel, Product Manager at TVM said: "Eye problems in pets are common and brachycephalic breeds are particularly prone to them due to a number of compounding factors.
"They commonly suffer from corneal ulcers and are nearly four times more likely to develop dry eye than other breeds, so Pet Eye Health Awareness Week is focused on helping pet owners understand the issues, identify eye problems early and seek veterinary advice quickly".
www.tvm-uk.com/eyehealth
Fees will now be £340 for a UK-practising member, £170 for members practising outside the UK, £56 for non-practising vets under the age of 70, and free for non-practising vets over 70.
Restoration fees, charged in addition to retention fees, increase to £85 following voluntary removal, and £340 following removal for non-payment.
Lizzie Lockett, RCVS CEO, said: "This year we asked Council to agree a fee increase to help us prepare for unknowns such as Brexit, as well as fortify our proactive work to help support the professions.
"Over the past few years we have put increased resources into projects such as: Mind Matters, our mental health initiative; Vet Futures, our joint project with the British Veterinary Association; Vivet, our innovation hub; and our recently launched Leadership Programme. Unfortunately there has also been a rise in Disciplinary Committee hearings and we are having to allocate further funds to making our building fit for purpose, and so a small increase has been necessary.
"This still places us at the lower end of fees for regulatory bodies while providing a secure financial foundation."
Eastcott says all staff working in the ECC unit have received specific intensive care training and will be supported by discipline-specific specialists at all times.
The service will be run by three ECC/medicine vets during the day and three ECC vets at night, supported by four day nurses and two night nurses.
David said: “We’ve created a purpose-built intensive care unit with all the latest ICU equipment, including our own laboratory; critical care cribs; temperature, humidity and oxygen-controlled intensive care kennels and an ICU ventilator.
“This means we have the facilities to care for the most severely injured and critical cases.
“We also have a high-quality team of enthusiastic, dedicated ECC vets and nurses to lead the service. Everyone has a background of ECC work and a true passion for it.”
Harriet said: “By having all the specialist disciplines available at the practice, we can offer a more holistic service to emergency patients. For example, if a dog is involved in a road traffic accident, the ICU can stabilise it and give emergency care and pain relief.
“Dentistry can then repair jaw and mouth injuries; orthopaedics can repair any other broken bones and soft tissue can assess and repair any damaged organs. This is all supported by our dedicated anaesthesia service and advanced imaging capabilities.
“The ICU also provides a calm environment for critically ill and injured patients to recover following surgery or other planned treatments from other disciplines.”
For more information, visit www.eastcottreferrals.co.uk.
60 vets took part in the survey. 80% believed they had seen an increase in behavioural problems since lockdown. Over 60% reported an increase in the incidence of obesity and diarrhoea. Nearly 50% had seen an increase in urinary tract disorders and haemorrhagic gastroenteritis.
When asked which conditions had been harder to manage clinically since the start of the pandemic, the top seven conditions were:
Medicine specialist, Dr Stefanie Mitze (pictured right) said: “We conducted the survey to help us understand changes in disease incidence and the clinical challenges faced by our colleagues in first opinion practice over the last year.
"The fact that the incidence of disorders which can have a stress-related component, including behavioural problems, diarrhoea and urinary tract disease, were reported to have increased by a high proportion of respondents indicates that many pets may be experiencing heightened stress during the pandemic.”
Stefanie is now creating a series of free bitesize CPD videos to help manage these more challenging cases. She said: “We recognise the past year has been challenging, especially with complex staffing issues, reduced vet visits and restricted face-to-face communication with clients. For complex, chronic medical conditions, especially those which require frequent follow up, we wanted to support colleagues in providing the best care possible in the current circumstances. We hope these CPD sessions will provide practical tips to help deliver just that.
The CPD sessions are available at: https://www.hamiltonspecialists.vet
Part of the VN Futures project, the lunchtime webinars will be delivered between February and June 2020 via the Webinar Vet, and the College is encouraging all veterinary surgeons, nurses, practice managers and owners to attend, as it says the webinars will benefit the whole practice team.
All three webinars take place at 12.30pm and last one hour. They are as follows:
Tuesday 4 February 2020 – ‘Maximising the potential of the veterinary nurse’ presented by Louise Northway RVN, BVNA Council member and recipient of the RCVS Inspiration Award. The webinar will give an overview of the role of veterinary nurses under Schedule 3 of the Veterinary Surgeons Act, how VNs can develop their role in practice and take on extra responsibilities and how VNs can approach these conversations in practice through the creation of learning and development plans. This webinar will illustrate how fully utilising the nursing team not only hugely boosts the morale of the work force, but also enhances patient care and increases the efficiency of the business.
Tuesday 10 March 2020 – ‘Veterinary nurses’ time is valuable: How and why to charge for it’ presented by Stephanie Writer-Davies MRCVS, Career Progression Working Group member, and Jane Davidson RVN, VN Council member and regular blogger on veterinary nursing issues. This webinar will provide examples and case studies of how veterinary nurses contribute to practice finances, how practice pricing structures can be developed so that the financial value of veterinary nurses’ time and effort can be better highlighted, and how veterinary nurses can demonstrate their value to clients.
Tuesday 23 June 2020 – ‘Lead or Head RVN: What’s in a name?’ presented by Gillian Page RVN, President of the Veterinary Management Group. This webinar will look at the role of the traditional Head RVN and how development of ‘Lead RVNs’ in different areas of practice can help to allow for growth of other talented team members and provide increased and shared responsibility and progression. This webinar will explore how this enhances practice efficiency alongside development of team members, thus increasing job satisfaction and, ultimately, retention.
Racheal Marshall, Chair of RCVS Veterinary Nurses Council and the VN Futures Board, said: "We hope that veterinary nurses will engage with these webinars in order to gain some inspiration about how they can truly show their value to their team, their clients and the wider public.
"The VN Futures research clearly demonstrated that there was a desire from the veterinary nursing profession to find ways in which VNs could gain greater recognition for the work they do and progress in their careers. These webinars, and our talented presenters, will provide many practical examples and case studies on how this can be done, help build confidence and highlight opportunities for further learning and development."
To sign up to the free webinars, visit: https://www.thewebinarvet.com/sponsors/VN%20Futures.
Overall, there has been a 17% decline in Kennel Club registrations of all dogs so far this year.
However, new registrations of Pugs, French Bulldogs and English Bulldogs have declined by 42%, 39% and 34% respectively, putting these three breeds into the list of 'top five fallers' this year.
The Brachycephalic Working Group (BWG), which is made up of vets, national animal welfare organisations, scientists, and dog breed clubs has welcomed the news.
Dan O’Neill, Chair of the BWG said: “The drop in puppy registrations for these flat-faced breeds is a welcome step in the right direction, although these should be seen with some caution.
“We hope this is a sign that more and more puppy buyers, owners and breeders are considering the serious health and welfare implications for flat-faced dogs.
ukbwg.org.uk
The Kennel Club has announced that it now recognises the Portuguese Pointer, bringing the total number of recognised pedigree breeds in the UK to 212.
The Portuguese Pointer is only the second new breed to be recognised by the Kennel Club in the last five years.
However, as exotic dog breeds have risen in popularity, the Kennel Club reports that many native breeds have fallen out of favour and have been put on its list of 'vulnerable native breeds'; those with less than 300 annual puppy registrations which could disappear from our streets and parks if their numbers continue to decline.
New statistics released by the Kennel Club have shown that whilst vulnerable native breeds have increased in number this year, certain breeds such as the Sealyham Terrier and Otterhound continue to decline. Recent years have seen the Old English Sheepdog and English Setter enter the 'at watch' list. Furthermore, with just 239 Pembroke Corgi registrations so far this year, it is feared the Queen's favourite breed could also become vulnerable for the first time.
By contrast, exotic breeds such as the French Bulldog and Smooth Coated Chihuahua (originally from Mexico) are increasing in popularity with 4,843 and 2,931 registrations respectively so far this year. Between 2003 and 2012 the breeds have increased by 1,232% and 700% respectively.
When the first ever Kennel Club stud book was produced in 1874, just 43 breeds were listed, including many native breeds that are now considered to be vulnerable, such as the Dandie Dinmont Terrier, Clumber Spaniel, Otterhound and Skye Terrier.
Some native breeds continue to thrive, including the English Springer Spaniel, the Cocker Spaniel, the Staffordshire Bull Terrier, the Bulldog, the Golden Retriever, and the Border Terrier, all top ten breeds. But others in the top ten are from abroad.
Visitors to Discover Dogs, which is taking place at Earls Court on November 9th and 10th will be able to meet more than 200 breeds of dog under one roof, including the vulnerable breeds and the latest pedigree dog breeds in the UK.
The newly added Turkish Kangal Dog will also be coming to the event. This breed was added earlier this year and was the first new breed to join the Kennel Club register in almost five years. The Greater Swiss Mountain Dog, officially recognised from 1 October 2008, was the last dog recognised by the Kennel Club prior to the two new additions for this year. Organiser of the Kennel Club's Discover Dogs event, Vanessa McAlpine, said: "The UK is lucky to have so many wonderful dog breeds, and at our Discover Dogs event people have a unique opportunity to meet more than 200 of them, including those that might never cross your path in day to day life because they are so rare, those that are new to our shores and those that have been working with people in Britain for hundreds of years."
To find out more about Discover Dogs, visit www.discoverdogs.org.uk/.
The booklet contains practical advice on handling rabbits, anaesthetic drugs, procedures and what to look out for from the moment the rabbit arrives into the practice up to recovery and homecare. Special attention is given to reducing anxiety in rabbit patients as much as possible at every stage.
Topics covered in the booklet include: medications in rabbits generally used according to the UK prescribing cascade, preparing for rabbit anaesthesia in clinic, staff training, an overview of anaesthetic drugs, the induction process and important points of difference, monitoring and recovery and adjunctive treatments.
Richard Beckwith, country manager of Jurox said: "Rabbits are prey species and often become stressed in the veterinary practice environment which can have a negative impact during anaesthesia and post-anaesthesia. Our new Considerations for Anaesthetising Rabbits expert panel guidelines booklet will help address this and raise anaesthesia and analgesia standards in veterinary practices."
For more information, visit www.alfaxan.co.uk, contact Jurox customer services on info@jurox.co.uk or telephone 0800 500 3871.
The deal is expected to complete by the middle of 2020.
According to the terms of the deal, Vetoquinol will acquire the Profender and Drontal product families, the intellectual property, registrations and other rights currently owned by Bayer AG’s animal health business.
Jeff Simmons, president and CEO of Elanco said: "We’re pleased with the continued progress on a number of fronts to move the acquisition of Bayer AG’s animal health business toward completion.
Matthieu Frechin, CEO of Vetoquinol, said: "We are very pleased to acquire the Profender and Drontal product lines that are highly valued by veterinarians and pet owners. The acquisition of these two strong brands is at the heart of our strategy. On the one hand, they will significantly increase the size of our business and our visibility in the parasiticide segment, one of our strategic therapeutic areas. On the other hand, they will strengthen our portfolio of Essentials, the engine of our growth."
The definition agreed by VN Council is as follows:
Veterinary nursing aims to ease the suffering and pain of animals, and to improve their health and welfare.
This includes providing any medical treatment or any minor surgery (not involving entry into a body cavity) to animals under the direction of a veterinary surgeon who has that animal under their care.
Veterinary nursing can be either proactive or reactive, and autonomous or collaborative. It is carried out in a wide variety of settings, for animals at all life stages, and considers the background and needs of the animal’s owner or keeper.
Matthew Rendle RVN, the Chair of VN Council, said: “Although it is just a few short lines, this definition of veterinary nursing has been in the pipeline for some time.
"While we as veterinary nurses have always been able to define ourselves by the type of tasks we carry out, or our relation to veterinary surgeons in terms of delegation, there hasn’t necessarily been a clear statement articulating the art and science of veterinary nursing.
“With the RCVS looking to expand its regulatory remit to include other veterinary paraprofessionals over the long term, we thought it was particularly important that we set out the stall for veterinary nursing and we hope that this clear statement will, in particular, aid the public in understanding the role of a veterinary nurse.
“It should be noted that this definition is VN Council’s own considered interpretation of the art and science of veterinary nursing.
"Other interpretations from other organisations, provided they conform with both Schedule 3 of the Veterinary Surgeons Act and the RCVS Code of Professional Conduct, could sit comfortably alongside ours, and we hope there continues to be healthy discussion about the contribution of the profession to the veterinary team, as our role evolves.”
Bayer Animal Health has launched a new version of Drontal which is presented as a bone-shaped tablet.
The company says that this is the UK's first worming tablet shaped like a bone, and that the product is designed to help improve client compliance.
Dan White, Group Product Manager at Bayer Animal Health said: "Almost half of dog owners - surveyed prior to launch - indicated that new Drontal bone would encourage them to worm their dogs more routinely. This is clearly great news for practices especially during these difficult economic times.
The launch of Drontal bone will be supported by a marketing drive that includes a new advertising creative concept which will be featured as part of a national TV advertising campaign, and an online consumer-facing competition called Give Your Dog A Bone designed to engage further with dog owners and communicate the benefits of having a worm-free dog.
Dan added: "The online and supporting consumer PR campaign will bring to life the special bond between pet and owner, and celebrate the happiness that dogs bring to our lives when they are happy, healthy and worm-free."
Practices can request a practice support pack to promote the availability of Drontal bone which will include a notice board picture-pack aimed at dog owning clients by calling their Bayer Territory Manager or 01635 563380.
The Give Your Dog a Bone competition and PR campaign has been devised by leading healthcare communications agency Pegasus. The new 'bone-shaped' TV and print creative has been developed by the recently-appointed advertising agency Dinosaur and will launch in early 2012.
Drontal's Give Your Dog a Bone competition will be launched on 1st March 2012 at www.giveyourdogabone.co.uk.
Stone Lion Veterinary Hospital, a first opinion and referral practice in Wimbledon, has announced that European Specialist in Veterinary Neurology Dr Sergio Rodenas, DVM DipECVN has joined the team to work alongside the Hospital's existing Veterinary Neurologist Dr Clare Rusbridge BVMS PhD DipECVN MRCVS RCVS and European Specialist in Veterinary Neurology.
The practice says that this will allow it to offer a full neurology referral service five days a week.
Sergio joins Stone Lion from his current post as Clinical Instructor in Neurology and Neurosurgery at the Veterinary College, St Hyacinthe at the University of Montreal. Before moving to Canada, he worked at the Southern Counties Veterinary Specialist (SCVS), a small animal specialist referral practice in Ringwood, Hampshire. He qualified at the Veterinary School, University of Extremadura, Spain, in 1996 and has also worked in both Spain and France.
The Stone Lion Veterinary Hospital is part of the Goddard Veterinary Group. It offers referrals in neurology, ophthalmology and physiotherapy. The Neurology Referral Practice is run by Clare Rusbridge and was established in 1997. She said: "Neurology is our busiest referral practice, drawing patients from across the South East of England and sometimes further afield. We see it as a growth area and wanted to offer our clients a five day a week service to make it easier for them to come to us. Sergio's experience especially in spinal surgery will be a huge asset to us and will enable us to meet this goal. We're delighted to welcome him."
Sergio added: "I am delighted to join the Neurology Service at the Stone Lion Veterinary Hospital. The facilities, team and professionalism of the staff and the track record of the Goddard Veterinary Group will make an excellent environment in which to practice small animal Neurology at the highest level and to offer the best care to patients."
The Stone Lion Veterinary Hospital can be contacted on 020 8946 4228.
Sileo provides a micro-dose of dexmedetomidine hydrochloride, a selective alpha-2 adrenoceptor agonist which Zoetis says helps a dog calm down or remain calm yet fully functional in situations involving fear-eliciting sounds.
Sileo is presented as an oromucosal gel formulation in a 3ml oral syringe that can be used to apply multiple doses.
Zoetis says that its user-friendly application means that, once prescribed, it can be given by the dog owner and used only when needed for each noise anxiety event. It takes effect within 15 - 60 minutes and last for 2-3 hours. Should the fear-eliciting noise continue, further doses can be given at two hour intervals up to a total of five times during each noise event.
The company says that even when the full dosing limit is used, the dog will remain functional during treatment; the clinical effects of dexmedetomidine are dose-dependent and the anxiolytic effect is reached before the sedative effect.
Animal behaviourist, Jon Bowen BVetMed DipAS (CABC) MRCVS, said: "Fear of seasonal loud noises such as fireworks, thunder and gunshots are known to affect around 50% of the UK dog population but the prevalence of fears of other everyday noises and the extent to which those fears contribute to nuisance and problem behaviour in dogs is something we are researching at the moment. Sileo is ideal as an acute anxiolytic for planned or expected events such as fireworks or thunder, but it has an even wider range of potential applications in planned events that involve stressful noise exposure including travel, social gatherings and even visits to the vet."
Sileo is available to order now via your veterinary wholesaler.
For more information contact your Zoetis account manager or customer support on 0854 300 8034 or visit www.zoetis.co.uk/Sileo.
The forecast formed part of the Association's response to the Environment Food and Rural Affairs Committee (EfraCom) inquiry into the impact on the UK’s trade in food after Brexit.
The BVA says that if the UK is treated as a 'third country' post Brexit, exports and imports of animals and animal products to and from the EU will need new veterinary certifications.
The UK Chief Veterinary Officer, Nigel Gibbens, says the volume of products requiring veterinary certifications could increase by as much as 325% as a result.
There are currently 1,063 Official Veterinarians authorised by the Government’s Animal and Plant Health Agency (APHA) to certify food products for export to third countries from Great Britain, a number which the BVA says would have to be significantly increased.
The BVA is urging the Government to undertake a major review of third country certification to ensure we have the capacity to fulfil new trade agreements. To combat the potential shortage in veterinary capacity, BVA is also calling on the Government to guarantee working rights for non-British EU vets and veterinary nurses currently working and studying in the UK.
British Veterinary Association Senior Vice President, Gudrun Ravetz said: "Vets are absolutely vital to facilitating UK trade by ensuring standards so that consumers at home and abroad have confidence in the food safety and welfare of the products they choose to buy. Veterinary certification is required not only for meat, but a whole range of products such as gelatine in sweets.
"Ironically, it is non-British EU vets who make up around 50% of our new workforce each year. However, since the EU referendum, we are facing serious problems in recruiting and retaining EU vets, which makes the need for more vets to perform this crucial trade-task an even more pressing concern. Vets’ role in the future of UK trade must be recognised and planned for, as an integral part of forthcoming trade negotiations."
The BVA trade submission also outlines that access to veterinary medicines could potentially be restricted post-Brexit. In order to protect animal and public health, BVA is calling for any new trade deal with the EU to maintain the link with EU veterinary medicine approval systems.
The UK currently has high standards of animal health, animal welfare and public health, including food safety, in its food production. These standards help prevent the spread of pathogens and diseases in animal products, ensure farm animals have a humane death, protect food safety and safeguard responsible antimicrobial use. BVA’s submission to the EfraCom trade inquiry emphasises that, as public goods, the UK must prioritise the maintenance of these standards in all trade negotiations moving forwards.
BVA’s full response to the EfraCom inquiry into the impact on the UK’s trade in food after Brexit is available on the BVA website at www.bva.co.uk/news-campaigns-and-policy/consultations/consultation-responses/
The first opinion Linnaeus Group practice, which also holds RCVS hospital status, is run by a team of nine vets, 14 nurses, nine receptionists and four animal care assistants.
It was given an outstanding rating for client service, inpatient service, patient consultation service and team and professional responsibility.
Maureen Geraghty Sathi, Practice Manager at Maven said: "We’re always asking ourselves how could we do this better? Everyone has to be on board or it would not work."
The practice had a focus team look at awards and the improvements it would need to make to achieve the required standards. Amongst the various things that were highlighted as exceptional were:
A genuinely separate cat waiting area and cat consult room.
An extensive pain monitoring system with pain scoring for all patients in hospital and an outpatient system which enables clients to monitor and chart their pets pain levels at home and review them with their vet.
Daily clinical rounds which involve the entire clinical team as well as management and a member of the customer care team. Aside from discussing clinical cases for the day this platform also enables daily review of any significant events or morbidity and mortality cases to be highlighted and time allocated for review.
A system whereby vets at the practice email clients in advance of any surgical procedure with information on the procedure itself as well as any potential risks associated with the procedure allowing time for further discussion with the client as needed
Consistent use of surgical and GA checklists to maximise patient safety.
In the final report, the RCVS practice standards assessor wrote: "The structures and management in place were of the very highest order. I was really impressed by the commitment of this practice to provide the very highest standards of clinical care to its clients."
Maureen said: "I am massively proud of the team, to see the pride in how they work. It is lovely to be told that you are working to an extremely high level and genuinely reflects the standards of the team day by day."
The virtual collection provides a source of evidence to determine what is or is not of clinical significance in cardiac arrhythmia and what might represent the best course of action, if action is needed, within the requisite parameters of safety and welfare.
With an editorial written jointly by Peter Physick-Sheard and Joann Slack the virtual collection includes:
... and more.
Professor Celia Marr, Editor of the EVJ said: “In terms of day-to-day veterinary work, rhythm disturbances are a frequent frustration during prepurchase examinations or perceived poor performance assessments. This outstanding collection brings to hand the most recent evidence to help clinicians support their observations, facilitating diagnosis and a treatment plan in this challenging area.”
The Virtual issue can be downloaded here: https://beva.onlinelibrary.wiley.com/doi/toc/10.1111/(ISSN)2042-3306.irregular-hearts-performance.vi
The book contains 40 chapters of articles about clinical techniques, diagnostic pathways and management approaches published in Companion between 2016 and 2020.
Editor of Companion, Samantha Taylor said: “At Companion we strive to produce well-illustrated, practical articles to help vets and VNs in practice face the day-to-day challenges of a varied caseload. We hope this collection meets our aims by covering a variety of clinical problems from hypercalcaemia in cats to managing the snuffly rabbit, from Leishmaniasis to lymphoma and many more.
Ian Ramsey (BSAVA Senior Vice President) said: “This collection represents a unique body of well-illustrated work prepared by experts from all around the UK and beyond. I would like to thank them all on behalf of BSAVA members and readers of this book for taking the time and care to develop these resources for their colleagues around the world.”
Samantha added: “Whether kept on the shelf for when needed or thumbed through over a cup of tea, we hope that within the pages of this new volume you find a useful tip or technique that helps.”
The How to…collected articles from BSAVA Companion (2016–2020), 3rd edition has been published as a BSAVA member loyalty reward gift for those eligible veterinary members who renew their membership this year.
The book is also available to buy from the BSAVA website www.bsava.com/shop priced at £20.
The workshop will be hosted by Renzo Di Florio (pictured right), veterinary advisor at Ceva Animal Health.
The session will look at the impact of Q Fever in the UK, outlining how it affects cattle health and reproductive performance and productivity.
It'll also cover identification of the disease and diagnosis, and prevention through vaccination and treatment.
For further information and to book tickets for TotalDairy, visit www.totaldairy.com (Ceva can offer a 10% discount on the purchase of tickets to the event using the code CEVA10).
The RCVS Disciplinary Committee has reprimanded Gloucestershire veterinary surgeon Adele Lewis for failing to pass on information about a horse’s clinical history to a potential buyer during a pre-purchase examination.
Ms Lewis, the sole principal of the Cotswold Equine Clinic in Lechlade, Gloucestershire, carried out the examination of a pony called Luke on 13 February 2014. Luke was owned by Mrs Booth who was a long-established client of Ms Lewis, both at her previous practice, Bourton Vale, and at her current practice. The examination was carried out on behalf of the prospective purchaser, Mrs Grieve.
Upon examination Ms Lewis certified that, in her opinion, Luke’s veterinary history did not increase the risk of purchase.
Following the purchase of Luke, Mrs Grieve attempted to obtain insurance for Luke and found out from a pet insurance company that a claim had been made by Mrs Booth in September 2013. She subsequently found out that, following concerns expressed by Mrs Booth and her trainer about Luke’s movement and their wanting an expert opinion, Ms Lewis had referred him to Dr Kold, a Specialist in Equine Orthopaedics, in September 2013. Dr Kold had diagnosed Luke with lameness and had given him intra-articular medication. Luke had also had a follow-up appointment with Dr Kold about four weeks later in October 2013.
The Disciplinary Committee hearing commenced on Tuesday 13 October 2015. At the outset, Ms Lewis admitted several parts of the charges (charge A and charge B) against her. In regards to charge A, she admitted that she had failed to inform Mrs Grieve that, when she examined Luke on 24 September 2013, his then owner Mrs Booth had complained firstly that Luke was “not tracking up and going forward” and, secondly, that he had improved significantly when put on a Phenylbutazone trial. She also admitted that she had referred him to Dr Kold for a poor performance investigation and that she ought to have informed Mrs Grieve of these matters.
In regards to charge B, she admitted that she completed a Certificate of Veterinary Examination in which she had declared that Luke’s veterinary history did not increase the risk of purchase and allowed the vendor’s declaration to include assertions that there had been no previous lameness and no intra-articular medication given in the last 12 months. Ms Lewis admitted that she ought to have known that her declaration that Luke’s veterinary history did not increase the risk of purchase was incorrect.
However, Ms Lewis denied being aware that Dr Kold had diagnosed lameness, administered an intra-articular corticosteroid to Luke and examined and noted a problem with his breathing, including upper airway disease and possible lower airway disease. Furthermore, she denied dishonesty in regards to both the charges against her and in relation to vendor declarations made on the Certificate of Veterinary Examination regarding previous lameness and intra-articular medication.
During the course of the hearing, Ms Lewis told the Committee that she had not received the reports about the two consultations by Dr Kold (despite their having been sent to her by letter and, with respect to the second report, also by email) and that she was therefore unaware of his findings when she carried out the pre-purchase examination. She also stated that she had not been informed of these by Mrs Booth. During her evidence, Ms Lewis also admitted having entered inaccurate information on a veterinary report to assist with an insurance claim.
The Committee did not find Ms Lewis to be an impressive witness citing the fact that her “explanations as to her practice showed a worrying absence of probity in the completion of veterinary reports for the purposes of insurance claims, and an absence of any effective practice management, consistent with acceptable practice.”
However, the Committee felt it did not have the evidence to conclude that Ms Lewis had acted dishonestly during the pre-purchase examination. It cited the fact that her actions, when informed by the purchaser Mrs Grieve of Dr Kold’s examination, did not appear to be those of someone trying to cover their tracks.
In regards to charge A, the Committee also found that the “apparently chaotic manner in which Ms Lewis ran her practice, and her own opinion that the pony was sound, would appear to have led her to wrongly disregard these matters from disclosure.”
In making its decision on her conduct and sanction, the Committee said that Ms Lewis’ failure to fully communicate to Mrs Grieve all the relevant information about Luke’s veterinary history fell far short of the conduct expected from a veterinary surgeon. It also cited the utmost importance of a complete and accurate certification process, as made clear in the RCVS Code of Professional Conduct and the Twelve Principles of Certification.
Chitra Karve, chairing the Committee and speaking on its behalf, said: “The Committee continues to emphasise the importance of maintaining the integrity of veterinary certification in any aspect of practice. Mrs Grieve told this Committee that if she had been fully informed about Luke’s veterinary history she would not have purchased the pony. It is clear from the evidence that it affected Mrs Grieve’s ability to insure the pony. Ms Lewis has accepted that the information about Luke’s veterinary history, not having been disclosed, was capable of affecting the risk of purchase. The public are entitled to rely upon veterinary surgeons providing complete and accurate information, when certificates and reports are prepared.”
In mitigation, the Committee paid regard to Ms Lewis’ inexperience at running her own practice and found no issue with her competence or clinical ability as a veterinary surgeon. It concluded that she had acted out of character and that there was no financial motivation for her actions. It also found it “highly relevant that the facts admitted and found proved related to a single pre-purchase examination.”
It also noted that Ms Lewis has now put in place a practice management system and has shown insight into her actions, by taking active steps to better comply with her obligations under the Code of Professional Conduct. She had also made early admissions of guilt and made a full apology to both Mrs Grieve and the RCVS both at the outset of the hearing, and in her evidence.
Chitra Karve added: “Having had the opportunity of observing her demeanour at this hearing, the Committee believes that it is unlikely that she will repeat her conduct.... The Committee has concluded that an appropriate and proportionate response in this case is to reprimand Ms Lewis.”